
Azra Raza
Director, Myelodysplastic Syndrome Center · Vagelos College of Physicians and Surgeons
Credentials: · · · · ·
History
PresentMyelodysplastic Syndrome Center · Vagelos College of Physicians and Surgeons
- Present
Roswell Park Memorial Hospital
Georgetown University Hospital
- Until 1979
Franklin Square Hospital
Research
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
New England Journal of Medicine · 2012 · 1,753 citations
Clinical effect of point mutations in myelodysplastic syndromes
New England Journal of Medicine · 2011 · 1,339 citations
Cancer · 2006 · 1,286 citations

20 papers

20 papers

20 papers
- SG
20 papers

16 papers
- HG
14 papers
- BL
13 papers

12 papers
Grants
- 2009–2012
Prediction of Response to Revlimid
National Heart, Lung, and Blood Institute · R21
Contact PI · $399.4K · Columbia University Health Sciences
- 2004–2009
National Center for Research Resources · P20
Project lead · $1M · University of Nebraska Lincoln
- 1997–2003
Secondary Hematologic Disorders--Genesis and Treatment
National Cancer Institute · P01
Contact PI · $5.4M · Rush University Medical Center
- 1992–1997
Studies of Cellular Proliferation in Myeloid Leukemias
National Cancer Institute · R01
Contact PI · $1.5M · Rush University Medical Center
Clinical trials
- 2009–2015
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Principal investigator · Completed · Phase 1
Traws Pharma, Inc.
- 2009–2014
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
Principal investigator · Completed · Phase 1, Phase 2
Traws Pharma, Inc.

